Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$TXG Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.14 down -150.00% YoY • Reported revenue of $151.04M down -12.65% YoY • 10x Genomics is raising its full year 2026 revenue guidance and now expects revenue in the range of $610 million to $630 million, representing 2% to 5% growth over 2025.

Price since post

Full Details

Advertisement|Remove ads.